首页> 外文OA文献 >Urokinase thrombolysis as a rescue treatment for midgut volvulus ischemia
【2h】

Urokinase thrombolysis as a rescue treatment for midgut volvulus ischemia

机译:尿激酶溶栓治疗中肠扭转性肠缺血

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Midgut volvulus in infants may lead to extreme short bowel syndrome. Strategies to avoid post-ischemia bowel loss have been proposed, involving thrombolysis prior to a definitive surgical treatment. Haemorrhagic risks in these patients may withhold from this approach. Herein we describe the use of urokinase systemic infusion after an unsatisfactory second look laparotomy, performed in a term baby with midgut volvulus. Continuous infusion of urokinase was given for seventeen hours prior to a third laparotomy. A total of 25 cm of small bowel were finally kept in place. Twelve months after the 1st laparotomy the patient was on oral feeding 125 calories/Kg/day. This case showed the possible rescue role of a fibrinolytic agent against persistent ischemia after the second look laparotomy for neonatal volvulus.
机译:婴幼儿肠中肠扭转可能导致极短肠综合征。已经提出了避免局部缺血后肠丢失的策略,包括在确定的外科治疗之前进行溶栓。这些患者的出血风险可以通过这种方法来避免。在本文中,我们描述了在足月肠扭转足月足月儿进行的剖腹手术效果不理想之后,使用尿激酶全身输注的方法。在第三次剖腹手术之前,连续输注尿激酶十七小时。最终总共保留了25厘米的小肠。第一次剖腹手术后十二个月,患者口服进食125卡路里/千克/天。该病例显示了针对新生儿肠扭转的第二次剖腹手术后,纤溶剂可能对持续性缺血具有挽救作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号